3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione

C102H106F3N29O4S2 — CID 157152743

IUPAC3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione
SMILESCN1C(=O)c2c(nn(Cc3ccc(-n4cncn4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CN1C(=S)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CSc1c2c(=O)n(C)c(=O)n(CC(C)(C)C)c2nn1Cc1ccc(C(C)(F)F)cc1.[H]/N=c1/c2c(Nc3ccccc3)n(Cc3ccc(-n4cncn4)cc3)nc2n(CC(C)(C)C)c(=O)n1C
InChIInChI=1S/C29H26FN7S.C26H25N9O.C26H29N9O.C21H26F2N4O2S/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21;1-32-25(36)22-23(29-18-6-3-2-4-7-18)33(14-17-10-12-19(13-11-17)34-16-27-15-28-34)31-24(22)35-21-9-5-8-20(21)30-26(32)35;1-26(2,3)15-33-24-21(22(27)32(4)25(33)36)23(30-19-8-6-5-7-9-19)34(31-24)14-18-10-12-20(13-11-18)35-17-28-16-29-35;1-20(2,3)12-26-16-15(17(28)25(5)19(26)29)18(30-6)27(24-16)11-13-7-9-14(10-8-13)21(4,22)23/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3;2-4,6-7,10-13,15-16,20-21,29H,5,8-9,14H2,1H3;5-13,16-17,27,30H,14-15H2,1-4H3;7-10H,11-12H2,1-6H3/b;;27-22-;/t22-,23+;20-,21+;;/m11../s1
InChIKeyALLGFVGUGLGTCM-TZMQNREESA-N
MW1923.30 g/mol
LogP16.29
Rot. Bonds21

About 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione

3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione (PubChem CID 157152743) has the molecular formula C102H106F3N29O4S2 and a molecular weight of 1923.30 g/mol. Its IUPAC name is 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione.

Molecular Properties

Compound Name3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione
PubChem CID157152743
Molecular FormulaC102H106F3N29O4S2
Molecular Weight1923.30 g/mol
Exact Mass1921.84
IUPAC Name3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione
SMILESCN1C(=O)c2c(nn(Cc3ccc(-n4cncn4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CN1C(=S)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CSc1c2c(=O)n(C)c(=O)n(CC(C)(C)C)c2nn1Cc1ccc(C(C)(F)F)cc1.[H]/N=c1/c2c(Nc3ccccc3)n(Cc3ccc(-n4cncn4)cc3)nc2n(CC(C)(C)C)c(=O)n1C
InChIInChI=1S/C29H26FN7S.C26H25N9O.C26H29N9O.C21H26F2N4O2S/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21;1-32-25(36)22-23(29-18-6-3-2-4-7-18)33(14-17-10-12-19(13-11-17)34-16-27-15-28-34)31-24(22)35-21-9-5-8-20(21)30-26(32)35;1-26(2,3)15-33-24-21(22(27)32(4)25(33)36)23(30-19-8-6-5-7-9-19)34(31-24)14-18-10-12-20(13-11-18)35-17-28-16-29-35;1-20(2,3)12-26-16-15(17(28)25(5)19(26)29)18(30-6)27(24-16)11-13-7-9-14(10-8-13)21(4,22)23/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3;2-4,6-7,10-13,15-16,20-21,29H,5,8-9,14H2,1H3;5-13,16-17,27,30H,14-15H2,1-4H3;7-10H,11-12H2,1-6H3/b;;27-22-;/t22-,23+;20-,21+;;/m11../s1
InChIKeyALLGFVGUGLGTCM-TZMQNREESA-N
XLogP16.29
TPSA331.21 Ų
H-Bond Donors4
H-Bond Acceptors33
Rotatable Bonds21
Heavy Atoms140
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001923.30
LogP ≤ 516.29
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione?
The IUPAC name of 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione (CID 157152743) is 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione.
What is the SMILES notation for 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione?
The canonical SMILES for 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione is CN1C(=O)c2c(nn(Cc3ccc(-n4cncn4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CN1C(=S)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.CSc1c2c(=O)n(C)c(=O)n(CC(C)(C)C)c2nn1Cc1ccc(C(C)(F)F)cc1.[H]/N=c1/c2c(Nc3ccccc3)n(Cc3ccc(-n4cncn4)cc3)nc2n(CC(C)(C)C)c(=O)n1C.
What is the InChIKey of 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione?
The InChIKey is ALLGFVGUGLGTCM-TZMQNREESA-N. The full InChI is InChI=1S/C29H26FN7S.C26H25N9O.C26H29N9O.C21H26F2N4O2S/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21;1-32-25(36)22-23(29-18-6-3-2-4-7-18)33(14-17-10-12-19(13-11-17)34-16-27-15-28-34)31-24(22)35-21-9-5-8-20(21)30-26(32)35;1-26(2,3)15-33-24-21(22(27)32(4)25(33)36)23(30-19-8-6-5-7-9-19)34(31-24)14-18-10-12-20(13-11-18)35-17-28-16-29-35;1-20(2,3)12-26-16-15(17(28)25(5)19(26)29)18(30-6)27(24-16)11-13-7-9-14(10-8-13)21(4,22)23/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3;2-4,6-7,10-13,15-16,20-21,29H,5,8-9,14H2,1H3;5-13,16-17,27,30H,14-15H2,1-4H3;7-10H,11-12H2,1-6H3/b;;27-22-;/t22-,23+;20-,21+;;/m11../s1.
What are the key properties of 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione?
3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione has a molecular weight of 1923.30 g/mol, XLogP of 16.29, 21 rotatable bonds, 4 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 3-anilino-7-(2,2-dimethylpropyl)-4-imino-5-methyl-2-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-one;(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridinyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-triene-7-thione;(11R,15S)-5-anilino-8-methyl-4-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;2-[[4-(1,1-difluoroethyl)phenyl]methyl]-7-(2,2-dimethylpropyl)-5-methyl-3-methylsulfanylpyrazolo[3,4-d]pyrimidine-4,6-dione is sourced from PubChem (CID 157152743), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).